Surgery Partners announces tie-up with Privia Health in Montana

02:13pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Surgery Partners (SGRY) enters into a strategic agreement with Privia Health (PRVA) whereby SGRY will leverage the physician enablement capabilities of PRVA in Montana.PRVA will build out
Investors who can spot the overpriced stocks and shun them at the right time are the ones likely to make a profit. SGRY, ASAI, BLKB and AZTA are a few toxic stocks that you should disown right away.
Surgery Partners <> is re-affirming its 2021 Adj. EBITDA guidance of $325M-$330M and its 2021 Revenue guidance of 19% to 21% growth over 2020 results.The Co
BRENTWOOD, Tenn., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announc
WCM Investment Management LLC lifted its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 0.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 155,088 shares of the companys stock after purchasing an additional 1,014 shares during the period. []

Is Now A Good Time To Invest In Surgery Partners Inc. (NASDAQ: SGRY)?

06:00pm, Saturday, 18'th Dec 2021 Stocks Register
Surgery Partners Inc. (NASDAQ:SGRY) shares, rose in value on Friday, 12/17/21, with the stock price up by 2.49% to the previous days close as strong demand from buyers drove the stock to $46.87. Actively observing the price movement in the last trading, the stock closed the session at $45.73, falling within a range of $43.97 Is Now A Good Time To Invest In Surgery Partners Inc. (NASDAQ: SGRY)? Read More »
Brokerages expect Surgery Partners, Inc. (NASDAQ:SGRY) to announce $0.26 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Surgery Partners earnings, with estimates ranging from $0.22 to $0.31. Surgery Partners reported earnings of $0.09 per share in the same quarter last year, which suggests []
Wells Fargo & Company MN boosted its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 37.3% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 57,192 shares of the companys stock after buying an additional 15,536 shares during the period. Wells Fargo & Company MNs holdings in Surgery Partners were worth $3,811,000 at []
Surgery Partners (NASDAQ:SGRY) had its price objective hoisted by SVB Leerink from $52.00 to $61.00 in a research note released on Friday, Stock Target Advisor reports. SVB Leerink currently has an outperform rating on the stock. SVB Leerink also issued estimates for Surgery Partners Q2 2023 earnings at $0.07 EPS and Q3 2023 earnings at []

Surgery Partners (NASDAQ:SGRY) Lifted to C at TheStreet

07:02am, Friday, 03'rd Dec 2021 Transcript Daily
TheStreet upgraded shares of Surgery Partners (NASDAQ:SGRY) from a d+ rating to a c rating in a research note published on Monday morning, TheStreetRatingsTable reports. A number of other research firms have also commented on SGRY. Stifel Nicolaus raised shares of Surgery Partners from a hold rating to a buy rating and set a $51.00 []

Surgery Partners (NASDAQ:SGRY) Trading 5.1% Higher

05:20pm, Thursday, 02'nd Dec 2021 Dakota Financial News
Shares of Surgery Partners, Inc. (NASDAQ:SGRY) traded up 5.1% during trading on Thursday . The company traded as high as $44.69 and last traded at $44.50. 6,670 shares changed hands during trading, a decline of 98% from the average session volume of 405,461 shares. The stock had previously closed at $42.36. A number of equities []
Marks important step in planned expansion of the CompuFlo Epidural instrument into the pain management market Marks important step in planned expansion of the CompuFlo Epidural instrument into the pain management market
Barclays started coverage on shares of Surgery Partners in a research report sent to investors on Tuesday morning, Analyst Ratings Network reports. The brokerage issued an
Barclays started coverage on shares of Surgery Partners (NASDAQ:SGRY) in a research report sent to investors on Tuesday morning, Analyst Ratings Network reports. The brokerage issued an overweight rating and a $73.00 price objective on the stock. Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. started coverage [] The post Surgery Partners (NASDAQ:SGRY) Receives New Coverage from Analysts at Barclays appeared first on ETF Daily News .
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE